- Home
- CCG vs CRBP Comparison
CCG vs CRBP Comparison
Compare CCG & CRBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCG
- CRBP
- Stock Information
- Founded
- CCG 2014
- CRBP 2009
- Country
- CCG China
- CRBP United States
- Employees
- CCG N/A
- CRBP N/A
- Industry
- CCG
- CRBP Biotechnology: Pharmaceutical Preparations
- Sector
- CCG
- CRBP Health Care
- Exchange
- CCG Nasdaq
- CRBP Nasdaq
- Market Cap
- CCG 75.1M
- CRBP 73.4M
- IPO Year
- CCG N/A
- CRBP N/A
- Fundamental
- Price
- CCG $0.83
- CRBP $6.65
- Analyst Decision
- CCG
- CRBP Strong Buy
- Analyst Count
- CCG 0
- CRBP 10
- Target Price
- CCG N/A
- CRBP $53.56
- AVG Volume (30 Days)
- CCG 252.7K
- CRBP 148.0K
- Earning Date
- CCG 05-29-2025
- CRBP 05-06-2025
- Dividend Yield
- CCG N/A
- CRBP N/A
- EPS Growth
- CCG N/A
- CRBP N/A
- EPS
- CCG N/A
- CRBP N/A
- Revenue
- CCG $475,831,129.00
- CRBP N/A
- Revenue This Year
- CCG N/A
- CRBP N/A
- Revenue Next Year
- CCG $7.06
- CRBP $150.00
- P/E Ratio
- CCG N/A
- CRBP N/A
- Revenue Growth
- CCG 5.20
- CRBP N/A
- 52 Week Low
- CCG $0.56
- CRBP $4.64
- 52 Week High
- CCG $2.39
- CRBP $61.90
- Technical
- Relative Strength Index (RSI)
- CCG 44.58
- CRBP 48.86
- Support Level
- CCG $0.81
- CRBP $6.10
- Resistance Level
- CCG $0.88
- CRBP $8.07
- Average True Range (ATR)
- CCG 0.08
- CRBP 0.70
- MACD
- CCG 0.00
- CRBP -0.07
- Stochastic Oscillator
- CCG 14.18
- CRBP 26.50
About CCG Cheche Group Inc.
Cheche Group Inc is engaged in the operation of providing insurance transaction services, Software-as-a-Service (SaaS) services and other services in China.. It is China's independent technology-empowered platform for auto insurance transaction services by digital auto insurance transaction premiums and insurance technology companies. The company has reshaped the traditional auto insurance distribution and services value chain to create a digital platform by improving operational efficiencies, reducing transaction costs, and expanding distribution channels. Its business scope ranges from digital insurance transactions, SaaS platforms for insurance intermediaries, AI-driven insurance pricing and underwriting services, auto insurance services for new energy vehicle (NEV) manufacturers, etc.
About CRBP Corbus Pharmaceuticals Holdings Inc.
Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.